CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- S-1/A Offering Registration Statement
- 10-K Report Annual Report
- S-1 Offering Registration Statement
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 20 of 33 · 643 filings